BSTG insider filings
Biostage, Inc. — 33 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-07-10. Screen BSTG transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for BSTG between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Biostage, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-07-10 | 4/A | He Junli — CEO, Director | Grant/award (A): 267,616 (derivative) @ $0 | EDGAR |
| 2023-05-02 | 4 | Packard Ronald J — Director | Grant/award (A): 4,839 (derivative) @ $0 | EDGAR |
| 2023-04-12 | 4 | He Junli — CEO, Director | Grant/award (A): 732,384 (derivative) @ $0 · Grant/award (A): 488,256 (derivative) @ $0 | EDGAR |
| 2023-04-10 | 4 | DST Capital LLC — 10% owner | Purchase (P): 62,500 @ $6 · Other (J): 110,000 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | GREEN DAVID — CEO as of 2/28/2023, Director | Grant/award (A): 39,662 (derivative) @ $0 · Grant/award (A): 38,773 (derivative) @ $0 · Grant/award (A): 732,384 (derivative) @ $0 | EDGAR |
| 2023-01-27 | 4 | GREEN DAVID — CEO, Director | Grant/award (A): 47,651 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | He Junli — Director | Sale (S): 135 @ $6.83 | EDGAR |
| 2022-12-09 | 4 | DST Capital LLC — 10% owner | Option exercise/expiry (X): 7,000 @ $2 · Sale (S): 1,952 @ $7.17 · Option exercise/expiry (X): 7,000 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Yu Hong — PRESIDENT | Option exercise/expiry (X): 300,000 @ $2 · Sale (S): 83,676 @ $7.17 · Option exercise/expiry (X): 300,000 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | Chen Jing — Director | Option exercise/expiry (X): 174,000 @ $2 · Sale (S): 48,532 @ $7.17 · Option exercise/expiry (X): 174,000 (derivative) @ $0 | EDGAR |
| 2022-08-09 | 4 | DAMASIO JOSEPH LUIS JR — Chief Financial Officer | Grant/award (A): 116,156 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | Sanchez Herman — Director | Grant/award (A): 6,241 (derivative) @ $0 · Grant/award (A): 5,016 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | Chen Jing — Director | Grant/award (A): 6,241 (derivative) @ $0 · Grant/award (A): 5,016 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | Li Ting — Director | Grant/award (A): 6,241 (derivative) @ $0 · Grant/award (A): 5,016 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | He Junli — Director | Grant/award (A): 6,241 (derivative) @ $0 · Grant/award (A): 5,016 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | Shmerling James E. — Director | Grant/award (A): 6,241 (derivative) @ $0 · Grant/award (A): 5,016 (derivative) @ $0 | EDGAR |
| 2022-05-23 | 4 | Shmerling James E. — Director | Purchase (P): 16,892 @ $5.92 · Purchase (P): 8,446 (derivative) | EDGAR |
| 2022-05-23 | 4 | GREEN DAVID — Interim CEO, Director | Purchase (P): 63,345 @ $5.92 · Purchase (P): 31,673 (derivative) | EDGAR |
| 2022-05-20 | 4 | He Junli — Director | Grant/award (A): 6,813 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | Yu Hong — President | Grant/award (A): 22,089 (derivative) @ $0 | EDGAR |
| 2022-05-19 | 4 | DST Capital LLC — 10% owner | Purchase (P): 8,277 @ $5.92 · Purchase (P): 4,139 (derivative) | EDGAR |
| 2022-01-03 | 4 | Fodor William — Chief Scientific Officer | Grant/award (A): 196,103 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Yu Hong — President | Grant/award (A): 113,116 (derivative) @ $0 | EDGAR |
| 2021-11-30 | 4 | GREEN DAVID — Interim CEO, Director | Purchase (P): 72,464 @ $3.45 · Purchase (P): 36,232 (derivative) · Grant/award (A): 374,094 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | He Junli — Director | Grant/award (A): 10,895 (derivative) @ $0 · Grant/award (A): 8,727 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Sanchez Herman — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 18,035 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Li Ting — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 18,035 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Chen Jing — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 18,035 (derivative) @ $0 | EDGAR |
| 2021-11-10 | 4 | Shmerling James E. — Director | Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 18,035 (derivative) @ $0 | EDGAR |
| 2021-09-09 | 4 | DST Capital LLC — 10% owner | Purchase (P): 500,000 @ $2 · Purchase (P): 250,000 (derivative) | EDGAR |
| 2021-06-21 | 4 | DST Capital LLC — 10% owner | Purchase (P): 150,000 @ $2 · Purchase (P): 75,000 (derivative) | EDGAR |
| 2021-02-01 | 4 | Sanchez Herman — Director | Grant/award (A): 16,413 (derivative) @ $0 | EDGAR |
| 2020-09-15 | 4 | DST Capital LLC — 10% owner | Other (J): 51,500 (derivative) @ $0 · Other (J): 100,000 (derivative) @ $0 · Other (J): 100,000 (derivative) @ $0 · Other (J): 100,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Biostage, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K/A | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-15 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-04-14 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BSTG returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs